{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T15:55:19Z","timestamp":1753890919690,"version":"3.41.2"},"reference-count":63,"publisher":"Frontiers Media SA","funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["NSFC-81271823"],"award-info":[{"award-number":["NSFC-81271823"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2017.00478","type":"journal-article","created":{"date-parts":[[2017,4,24]],"date-time":"2017-04-24T14:11:51Z","timestamp":1493043111000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":5,"title":["The Membrane-Proximal Region of C\u2013C Chemokine Receptor Type 5 Participates in the Infection of HIV-1"],"prefix":"10.3389","volume":"8","author":[{"given":"Yue","family":"Tan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pei","family":"Tong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junyi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lei","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yang","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying-Hua","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ji","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2017,4,24]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"a007161","DOI":"10.1101\/cshperspect.a007161","article-title":"HIV-1 antiretroviral drug therapy","volume":"2","author":"Arts","year":"2012","journal-title":"Cold Spring Harb Perspect Med"},{"key":"B2","doi-asserted-by":"publisher","first-page":"e1002251","DOI":"10.1371\/journal.pbio.1002251","article-title":"Extremely high mutation rate of HIV-1 in vivo","volume":"13","author":"Cuevas","year":"2015","journal-title":"PLoS Biol"},{"key":"B3","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1146\/annurev.immunol.17.1.657","article-title":"Chemokine receptors as HIV-1 coreceptors: roles in viral entry, tropism, and disease","volume":"17","author":"Berger","year":"1999","journal-title":"Annu Rev Immunol"},{"key":"B4","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1084\/jem.185.4.621","article-title":"Change in coreceptor use correlates with disease progression in HIV-1-infected individuals","volume":"185","author":"Connor","year":"1997","journal-title":"J Exp Med"},{"key":"B5","doi-asserted-by":"publisher","first-page":"1884","DOI":"10.1016\/S0140-6736(05)63874-3","article-title":"Dual effect of CCR5 delta 32 gene deletion in HIV-1-infected patients. Copenhagen AIDS study group","volume":"349","author":"Garred","year":"1997","journal-title":"Lancet"},{"key":"B6","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1056\/NEJMoa0802905","article-title":"Long-term control of HIV by CCR5 Delta32\/Delta32 stem-cell transplantation","volume":"360","author":"Hutter","year":"2009","journal-title":"N Engl J Med"},{"key":"B7","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.1126\/science.1241475","article-title":"Structure of the CCR5 chemokine receptor-HIV entry inhibitor maraviroc complex","volume":"341","author":"Tan","year":"2013","journal-title":"Science"},{"key":"B8","doi-asserted-by":"crossref","first-page":"6305","DOI":"10.1128\/JVI.71.9.6305-6314.1997","article-title":"Two distinct CCR5 domains can mediate coreceptor usage by human immunodeficiency virus type 1","volume":"71","author":"Doranz","year":"1997","journal-title":"J Virol"},{"key":"B9","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1128\/JVI.72.2.1160-1164.1998","article-title":"A tyrosine-rich region in the N terminus of CCR5 is important for human immunodeficiency virus type 1 entry and mediates an association between gp120 and CCR5","volume":"72","author":"Farzan","year":"1998","journal-title":"J Virol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"1930","DOI":"10.1126\/science.1145373","article-title":"Structures of the CCR5 N terminus and of a tyrosine-sulfated antibody with HIV-1 gp120 and CD4","volume":"317","author":"Huang","year":"2007","journal-title":"Science"},{"key":"B11","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1126\/science.1118398","article-title":"Structure of a V3-containing HIV-1 gp120 core","volume":"310","author":"Huang","year":"2005","journal-title":"Science"},{"key":"B12","doi-asserted-by":"publisher","first-page":"4721","DOI":"10.1128\/AAC.49.11.4721-4732.2005","article-title":"Maraviroc (UK-427,857), a potent, orally bioavailable, and selective small-molecule inhibitor of chemokine receptor CCR5 with broad-spectrum anti-human immunodeficiency virus type 1 activity","volume":"49","author":"Dorr","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"key":"B13","doi-asserted-by":"publisher","first-page":"9617","DOI":"10.1074\/jbc.274.14.9617","article-title":"Epitope mapping of CCR5 reveals multiple conformational states and distinct but overlapping structures involved in chemokine and coreceptor function","volume":"274","author":"Lee","year":"1999","journal-title":"J Biol Chem"},{"key":"B14","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1084\/jem.186.8.1373","article-title":"Interaction of chemokine receptor CCR5 with its ligands: multiple domains for HIV-1 gp120 binding and a single domain for chemokine binding","volume":"186","author":"Wu","year":"1997","journal-title":"J Exp Med"},{"key":"B15","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1097\/QAD.0b013e3282f303e6","article-title":"HIV-1 escape to CCR5 coreceptor antagonism through selection of CXCR4-using variants in vitro","volume":"22","author":"Moncunill","year":"2008","journal-title":"AIDS"},{"key":"B16","doi-asserted-by":"publisher","first-page":"10863","DOI":"10.1128\/JVI.01109-10","article-title":"A maraviroc-resistant HIV-1 with narrow cross-resistance to other CCR5 antagonists depends on both N-terminal and extracellular loop domains of drug-bound CCR5","volume":"84","author":"Tilton","year":"2010","journal-title":"J Virol"},{"key":"B17","doi-asserted-by":"crossref","first-page":"4145","DOI":"10.1128\/JVI.73.5.4145-4155.1999","article-title":"Differential inhibition of human immunodeficiency virus type 1 fusion, gp120 binding, and CC-chemokine activity by monoclonal antibodies to CCR5","volume":"73","author":"Olson","year":"1999","journal-title":"J Virol"},{"key":"B18","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1124\/dmd.104.002626","article-title":"Species differences in the disposition of the CCR5 antagonist, UK-427,857, a new potential treatment for HIV","volume":"33","author":"Walker","year":"2005","journal-title":"Drug Metab Dispos"},{"key":"B19","doi-asserted-by":"crossref","first-page":"4018","DOI":"10.4049\/jimmunol.160.8.4018","article-title":"Impaired macrophage function and enhanced T cell-dependent immune response in mice lacking CCR5, the mouse homologue of the major HIV-1 coreceptor","volume":"160","author":"Zhou","year":"1998","journal-title":"J Immunol"},{"key":"B20","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1084\/jem.20042530","article-title":"Chemokine receptor CCR5 promotes leukocyte trafficking to the brain and survival in West Nile virus infection","volume":"202","author":"Glass","year":"2005","journal-title":"J Exp Med"},{"key":"B21","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1086\/524691","article-title":"Genetic deficiency of chemokine receptor CCR5 is a strong risk factor for symptomatic West Nile virus infection: a meta-analysis of 4 cohorts in the US epidemic","volume":"197","author":"Lim","year":"2008","journal-title":"J Infect Dis"},{"key":"B22","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1128\/JVI.75.2.579-588.2001","article-title":"Potent, broad-spectrum inhibition of human immunodeficiency virus type 1 by the CCR5 monoclonal antibody PRO 140","volume":"75","author":"Trkola","year":"2001","journal-title":"J Virol"},{"key":"B23","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.1056\/NEJMoa0803152","article-title":"Maraviroc for previously treated patients with R5 HIV-1 infection","volume":"359","author":"Gulick","year":"2008","journal-title":"N Engl J Med"},{"key":"B24","doi-asserted-by":"publisher","first-page":"2373","DOI":"10.1073\/pnas.96.5.2373","article-title":"Induction of autoantibodies to mouse CCR5 with recombinant papillomavirus particles","volume":"96","author":"Chackerian","year":"1999","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B25","doi-asserted-by":"publisher","first-page":"463","DOI":"10.4049\/jimmunol.176.1.463","article-title":"Effects of immunization with CCR5-based cycloimmunogen on simian\/HIVSF162P3 challenge","volume":"176","author":"Misumi","year":"2006","journal-title":"J Immunol"},{"key":"B26","doi-asserted-by":"publisher","first-page":"5752","DOI":"10.1016\/j.vaccine.2008.08.025","article-title":"HIV blocking antibodies following immunisation with chimaeric peptides coding a short N-terminal sequence of the CCR5 receptor","volume":"26","author":"Chain","year":"2008","journal-title":"Vaccine"},{"key":"B27","doi-asserted-by":"publisher","first-page":"4125","DOI":"10.1128\/JVI.02232-07","article-title":"Two amino acid substitutions within the first external loop of CCR5 induce human immunodeficiency virus-blocking antibodies in mice and chickens","volume":"82","author":"Pastori","year":"2008","journal-title":"J Virol"},{"key":"B28","doi-asserted-by":"publisher","first-page":"4825","DOI":"10.1182\/blood-2005-06-2463","article-title":"Long-lasting CCR5 internalization by antibodies in a subset of long-term nonprogressors: a possible protective effect against disease progression","volume":"107","author":"Pastori","year":"2006","journal-title":"Blood"},{"key":"B29","doi-asserted-by":"publisher","first-page":"34719","DOI":"10.1074\/jbc.274.49.34719","article-title":"Multiple charged and aromatic residues in CCR5 amino-terminal domain are involved in high affinity binding of both chemokines and HIV-1 Env protein","volume":"274","author":"Blanpain","year":"1999","journal-title":"J Biol Chem"},{"key":"B30","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1016\/j.jmb.2006.10.040","article-title":"Recognition of RANTES by extracellular parts of the CCR5 receptor","volume":"365","author":"Duma","year":"2007","journal-title":"J Mol Biol"},{"key":"B31","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1128\/JVI.05066-11","article-title":"Mutations of Gln64 in the HIV-1 gp41 N-terminal heptad repeat render viruses resistant to peptide HIV fusion inhibitors targeting the gp41 pocket","volume":"86","author":"Yu","year":"2012","journal-title":"J Virol"},{"key":"B32","doi-asserted-by":"publisher","first-page":"e45152","DOI":"10.1371\/journal.pone.0045152","article-title":"SVMTriP: a method to predict antigenic epitopes using support vector machine to integrate tri-peptide similarity and propensity","volume":"7","author":"Yao","year":"2012","journal-title":"PLoS One"},{"key":"B33","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1142\/9781848162648_0011","article-title":"Predicting flexible length linear B-cell epitopes","volume":"7","author":"El-Manzalawy","year":"2008","journal-title":"Comput Syst Bioinformatics Conf"},{"key":"B34","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/0014-5793(90)80535-Q","article-title":"A semi-empirical method for prediction of antigenic determinants on protein antigens","volume":"276","author":"Kolaskar","year":"1990","journal-title":"FEBS Lett"},{"key":"B35","doi-asserted-by":"publisher","first-page":"2533","DOI":"10.1093\/jac\/dkt230","article-title":"An engineered HIV-1 gp41 trimeric coiled coil with increased stability and anti-HIV-1 activity: implication for developing anti-HIV microbicides","volume":"68","author":"Tong","year":"2013","journal-title":"J Antimicrob Chemother"},{"key":"B36","doi-asserted-by":"publisher","first-page":"e18233","DOI":"10.1371\/journal.pone.0018233","article-title":"HIV-1 gp41 core with exposed membrane-proximal external region inducing broad HIV-1 neutralizing antibodies","volume":"6","author":"Wang","year":"2011","journal-title":"PLoS One"},{"key":"B37","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/1742-4690-5-27","article-title":"Aqueous extracts from peppermint, sage and lemon balm leaves display potent anti-HIV-1 activity by increasing the virion density","volume":"5","author":"Geuenich","year":"2008","journal-title":"Retrovirology"},{"key":"B38","doi-asserted-by":"publisher","first-page":"33516","DOI":"10.1074\/jbc.M007228200","article-title":"A tyrosine-sulfated peptide based on the N terminus of CCR5 interacts with a CD4-enhanced epitope of the HIV-1 gp120 envelope glycoprotein and inhibits HIV-1 entry","volume":"275","author":"Farzan","year":"2000","journal-title":"J Biol Chem"},{"key":"B39","doi-asserted-by":"publisher","first-page":"3623","DOI":"10.1128\/JVI.03663-13","article-title":"Induction of HIV-blocking anti-CCR5 IgA in Peyers\u2019s patches without histopathological alterations","volume":"88","author":"Pastori","year":"2014","journal-title":"J Virol"},{"key":"B40","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1038\/ni1027","article-title":"Identification of amino acid residues crucial for chemokine receptor dimerization","volume":"5","author":"Hernanz-Falcon","year":"2004","journal-title":"Nat Immunol"},{"key":"B41","doi-asserted-by":"publisher","first-page":"5762","DOI":"10.1073\/pnas.97.11.5762","article-title":"Specific interaction of CCR5 amino-terminal domain peptides containing sulfotyrosines with HIV-1 envelope glycoprotein gp120","volume":"97","author":"Cormier","year":"2000","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B42","doi-asserted-by":"publisher","first-page":"15076","DOI":"10.1074\/jbc.M111.332361","article-title":"Peptides from second extracellular loop of C-C chemokine receptor type 5 (CCR5) inhibit diverse strains of HIV-1","volume":"287","author":"Dogo-Isonagie","year":"2012","journal-title":"J Biol Chem"},{"key":"B43","doi-asserted-by":"publisher","first-page":"1537","DOI":"10.1093\/jac\/dku010","article-title":"Artificial peptides conjugated with cholesterol and pocket-specific small molecules potently inhibit infection by laboratory-adapted and primary HIV-1 isolates and enfuvirtide-resistant HIV-1 strains","volume":"69","author":"Wang","year":"2014","journal-title":"J Antimicrob Chemother"},{"key":"B44","doi-asserted-by":"publisher","first-page":"5801","DOI":"10.1073\/pnas.0901007106","article-title":"Addition of a cholesterol group to an HIV-1 peptide fusion inhibitor dramatically increases its antiviral potency","volume":"106","author":"Ingallinella","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B45","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1186\/1742-4690-9-104","article-title":"A bivalent recombinant protein inactivates HIV-1 by targeting the gp41 prehairpin fusion intermediate induced by CD4 D1D2 domains","volume":"9","author":"Lu","year":"2012","journal-title":"Retrovirology"},{"key":"B46","doi-asserted-by":"publisher","first-page":"a006866","DOI":"10.1101\/cshperspect.a006866","article-title":"HIV: cell binding and entry","volume":"2","author":"Wilen","year":"2012","journal-title":"Cold Spring Harb Perspect Med"},{"key":"B47","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1038\/nrd1331","article-title":"Enfuvirtide: the first therapy to inhibit the entry of HIV-1 into host CD4 lymphocytes","volume":"3","author":"Matthews","year":"2004","journal-title":"Nat Rev Drug Discov"},{"key":"B48","doi-asserted-by":"publisher","first-page":"6960","DOI":"10.1128\/JVI.00791-15","article-title":"Nonneutralizing antibodies induced by the HIV-1 gp41 NHR domain gain neutralizing activity in the presence of the HIV fusion inhibitor enfuvirtide: a potential therapeutic vaccine strategy","volume":"89","author":"Wang","year":"2015","journal-title":"J Virol"},{"key":"B49","doi-asserted-by":"publisher","first-page":"e1000509","DOI":"10.1371\/journal.ppat.1000509","article-title":"Membrane-anchored HIV-1 N-heptad repeat peptides are highly potent cell fusion inhibitors via an altered mode of action","volume":"5","author":"Wexler-Cohen","year":"2009","journal-title":"PLoS Pathog"},{"key":"B50","doi-asserted-by":"publisher","first-page":"1703","DOI":"10.1099\/0022-1317-73-7-1703","article-title":"A leucine zipper structure present in the measles virus fusion protein is not required for its tetramerization but is essential for fusion","volume":"73","author":"Buckland","year":"1992","journal-title":"J Gen Virol"},{"key":"B51","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1006\/viro.1998.9044","article-title":"The role of leucine residues in the structure and function of a leucine zipper peptide inhibitor of paramyxovirus (NDV) fusion","volume":"243","author":"Young","year":"1998","journal-title":"Virology"},{"key":"B52","doi-asserted-by":"crossref","first-page":"4748","DOI":"10.1128\/JVI.66.8.4748-4756.1992","article-title":"Mutations in the leucine zipper of the human immunodeficiency virus type 1 transmembrane glycoprotein affect fusion and infectivity","volume":"66","author":"Dubay","year":"1992","journal-title":"J Virol"},{"key":"B53","doi-asserted-by":"publisher","first-page":"12676","DOI":"10.1073\/pnas.91.26.12676","article-title":"Propensity for a leucine zipper-like domain of human immunodeficiency virus type 1 gp41 to form oligomers correlates with a role in virus-induced fusion rather than assembly of the glycoprotein complex","volume":"91","author":"Wild","year":"1994","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B54","doi-asserted-by":"publisher","first-page":"7606","DOI":"10.4049\/jimmunol.166.12.7606","article-title":"Antibodies to C-C chemokine receptor 5 in normal human IgG block infection of macrophages and lymphocytes with primary R5-tropic strains of HIV-1","volume":"166","author":"Bouhlal","year":"2001","journal-title":"J Immunol"},{"key":"B55","doi-asserted-by":"publisher","first-page":"2205","DOI":"10.1182\/blood-2004-06-2134","article-title":"CCR5-specific mucosal IgA in saliva and genital fluids of HIV-exposed seronegative subjects","volume":"104","author":"Barassi","year":"2004","journal-title":"Blood"},{"key":"B56","doi-asserted-by":"publisher","first-page":"1917","DOI":"10.1097\/00002030-200009080-00006","article-title":"Mucosal and plasma IgA from HIV-exposed seronegative individuals neutralize a primary HIV-1 isolate","volume":"14","author":"Devito","year":"2000","journal-title":"AIDS"},{"key":"B57","doi-asserted-by":"publisher","first-page":"3426","DOI":"10.4049\/jimmunol.164.6.3426","article-title":"CCR5-reactive antibodies in seronegative partners of HIV-seropositive individuals down-modulate surface CCR5 in vivo and neutralize the infectivity of R5 strains of HIV-1 in vitro","volume":"164","author":"Lopalco","year":"2000","journal-title":"J Immunol"},{"key":"B58","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1126\/science.1261064","article-title":"Structural biology. Crystal structure of the chemokine receptor CXCR4 in complex with a viral chemokine","volume":"347","author":"Qin","year":"2015","journal-title":"Science"},{"key":"B59","doi-asserted-by":"publisher","first-page":"S4","DOI":"10.1186\/1479-5876-9-S1-S4","article-title":"Natural anti-CCR5 antibodies in HIV-infection and -exposure","volume":"9","author":"Lopalco","year":"2011","journal-title":"J Transl Med"},{"key":"B60","doi-asserted-by":"publisher","first-page":"e00018","DOI":"10.1128\/mBio.00018-10","article-title":"Influenza virus vaccine based on the conserved hemagglutinin stalk domain","volume":"1","author":"Steel","year":"2010","journal-title":"MBio"},{"key":"B61","doi-asserted-by":"publisher","first-page":"e65","DOI":"10.1038\/emi.2016.86","article-title":"An immunogen containing four tandem 10E8 epitope repeats with exposed key residues induces antibodies that neutralize HIV-1 and activates an ADCC reporter gene","volume":"5","author":"Sun","year":"2016","journal-title":"Emerg Microbes Infect"},{"key":"B62","doi-asserted-by":"publisher","first-page":"4447","DOI":"10.1038\/ncomms5447","article-title":"A micro-sterile inflammation array as an adjuvant for influenza vaccines","volume":"5","author":"Wang","year":"2014","journal-title":"Nat Commun"},{"key":"B63","doi-asserted-by":"publisher","first-page":"5005","DOI":"10.1073\/pnas.1500408112","article-title":"Effective and lesion-free cutaneous influenza vaccination","volume":"112","author":"Wang","year":"2015","journal-title":"Proc Natl Acad Sci U S A"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fimmu.2017.00478\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,23]],"date-time":"2023-08-23T07:34:44Z","timestamp":1692776084000},"score":1,"resource":{"primary":{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fimmu.2017.00478\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4,24]]},"references-count":63,"alternative-id":["10.3389\/fimmu.2017.00478"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2017.00478","relation":{},"ISSN":["1664-3224"],"issn-type":[{"type":"electronic","value":"1664-3224"}],"subject":[],"published":{"date-parts":[[2017,4,24]]},"article-number":"478"}}